139 related articles for article (PubMed ID: 32276912)
1. Molecular docking, synthesis and biological evaluation of phenacyl derivatives of 9-aminoacridine as anti-Alzheimer's agent.
Munawar R; Mushtaq N; Ahmad A; Saeed SMG; Usmani S; Akhtar S; Saify ZS; Arif M; Akram A
Pak J Pharm Sci; 2020 Mar; 33(2):659-668. PubMed ID: 32276912
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents.
Munawar R; Mushtaq N; Arif S; Ahmed A; Akhtar S; Ansari S; Meer S; Saify ZS; Arif M
Am J Alzheimers Dis Other Demen; 2016 May; 31(3):263-9. PubMed ID: 26385945
[TBL] [Abstract][Full Text] [Related]
3. Design Synthesis and
Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
6. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.
Wu W; Liang X; Xie G; Chen L; Liu W; Luo G; Zhang P; Yu L; Zheng X; Ji H; Zhang C; Yi W
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301153
[TBL] [Abstract][Full Text] [Related]
8. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Wang H; Wang H; Ma Q; Han X; Ye M; Yu L; Liu W
Bioorg Med Chem Lett; 2017 Nov; 27(22):5046-5052. PubMed ID: 29033233
[TBL] [Abstract][Full Text] [Related]
10. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies.
Kumar J; Meena P; Singh A; Jameel E; Maqbool M; Mobashir M; Shandilya A; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2016 Aug; 119():260-77. PubMed ID: 27227482
[TBL] [Abstract][Full Text] [Related]
12. Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity.
Egbujor MC
Cent Nerv Syst Agents Med Chem; 2024; 24(1):82-104. PubMed ID: 38275073
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of aminothiazole derivatives as potential anti-Alzheimer's candidates.
Soni A; Kumar A; Kumar V; Rawat R; Eyupoglu V
Future Med Chem; 2024 Mar; 16(6):513-529. PubMed ID: 38375588
[No Abstract] [Full Text] [Related]
14. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease.
Mao F; Wang H; Ni W; Zheng X; Wang M; Bao K; Ling D; Li X; Xu Y; Zhang H; Li J
ACS Chem Neurosci; 2018 Feb; 9(2):328-345. PubMed ID: 29068218
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
[TBL] [Abstract][Full Text] [Related]
18. The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches.
Hassan M; Raza H; Abbasi MA; Moustafa AA; Seo SY
Biomed Pharmacother; 2019 Jan; 109():2513-2526. PubMed ID: 30551512
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
20. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
